Board of Directors
The Lundquist Institute Board of Directors plays a pivotal role in guiding the Institute’s strategic direction, ensuring fiscal responsibility, and fostering a culture of excellence.
Joseph Berenato | Chair
Former Chairman and CEO, Ducommun Inc.
Eric Daar, MD* | Vice Chair
Chief, Division of HIV Medicine, Harbor-UCLA Medical Center
Laura Survant | Vice Chair
Partner, Deloitte & Touche LLP
Delphine Lee, MD, PhD* | Secretary
Chief of Dermatology and Residency Program Director, Harbor-UCLA Medical Center
Tom Anastassiou | Treasurer
Managing Member, Paseo Capital Management LLC
Kelly Callahan, MD*
Chair, Department of Pediatrics, Harbor-UCLA Medical Center
Christian de Virgilio, MD*
Chair, Department of Surgery, Harbor-UCLA Medical Center
Andrew Foster
Partner, Boston Consulting Group
Griselda Gutierrez, MD
Chief Medical Officer, Harbor-UCLA Medical Center
Elliot Hinds
Partner, Sheppard Mullin
Christopher Lee, MD
Vice President of Pharmaceuticals and Biotechnology, Capital Group
Melanie Lundquist
Philanthropist
Richard Lundquist
President and CEO, Continental Development Corporation
Paul Mathews, PhD*
Director, Neurotherapeutics at The Lundquist Institute
Loren Miller, MD, MPH*
Associate Chief, Division of Infectious Diseases, Department of Medicine, Harbor-UCLA Medical Center
Steven A. Nissen
President and CEO, Hollywood Chamber of Commerce
Thomas A. Parham, PhD
President Emeritus, CSU Dominguez Hills
Joe W. Ramos, PhD
President and CEO, The Lundquist Institute
Harry B. Rossiter, PhD*
Chair, Research Committee and Director, Respiratory Medicine and Exercise Physiology, The Lundquist Institute
Mitchel Sayare, PhD
Chairman, Altimmune Inc.
Mathias Schmidt, PD, PhD
CEO, ArmaGen, Inc. and Executive Fellow and Advisor to the Chairman, JCR Pharmaceuticals, Ltd.
Joseph Thomas, MD*
Chair, Department of Medicine, Harbor-UCLA Medical Center
*Principal Investigator, The Lundquist Institute